Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Kolltan banks $60M to hit the gas on its cancer drug
Kolltan banks $60M to hit the gas on its cancer drug
Kolltan banks $60M to hit the gas on its cancer drug
Submitted by
admin
on March 27, 2014 - 8:20am
Source:
Fierce Biotech
News Tags:
Kolltan
monoclonal antibodies
KTN3379
Headline:
Kolltan banks $60M to hit the gas on its cancer drug
Do Not Allow Advertisers to Use My Personal information
